Topic: GlaxoSmithKline plc
CHICAGO (Reuters) - Mild to severe depression might be better treated with alternatives to antidepressant drugs, which do not help patients much more than an inactive placebo, researchers said Tuesday.Combining data from six studies that examined the effectiveness of two commonly prescribed ...
According to a report in The Philadelphia Enquirer, GlaxoSmithKline, manufacturer of the antidepressant Paxil, must pay $2.5 million to settle a claim that the drug caused severe heart defects in 3-year-old Bensalem, PA boy.. The verdict is the first in 600 similar ...
Court documents show Glaxo used CASPPER (the friendly ghostwriting program) to promote PaxilDrugmaker GlaxoSmithKline used a sophisticated ghostwriting program to promote its antidepressant Paxil, allowing doctors to take credit for medical journal articles mainly written by company consultants, according to court documents ...
Class-action settlements against drug companies, or anyone else, are typically advertised broadly to make sure potential members of the class can participate. But to get the word out about improved settlement terms in a class-action suit against GlaxoSmithKline over its antidepressant Paxil, ...
Litigation over GlaxoSmithKline's handling of information about the suicide risk from antidepressant Paxil has turned up some documents that say a lot about why the FDA often seems to be in the dark when problems with drugs surface.. Plaintiffs attorneys in Los ...
Parents who bought the antidepressant Paxil for their children can begin seeking reimbursements under a $64 million class-action deal settling claims that the drug's maker misled consumers about the medication's safety.Under the deal, announced in April and granted final approval last week ...
GOOD health is not what it used to be. One of the most striking examples of this is the "Sisi syndrome", an alleged form of depression that came to light for the first time in 1998 in a one-page advertisement by SmithKline ...